The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics

被引:40
|
作者
Schoonheim, Menno M. [1 ,2 ]
Broeders, Tommy A. A. [1 ]
Geurts, Jeroen J. G. [1 ]
机构
[1] Vrije Univ Amsterdam, MS Ctr Amsterdam, Dept Anat & Neurosci, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Anat & Neurosci, locat VUmc, POB 7057, NL-1007 MB Amsterdam, Netherlands
关键词
Multiple sclerosis; Network; Connectivity; Hub; Efficiency; Cognition; STATE FUNCTIONAL CONNECTIVITY; CLINICALLY ISOLATED SYNDROME; COGNITIVE IMPAIRMENT; BRAIN NETWORK; DISABILITY PROGRESSION; EARLY MS; DYSFUNCTION; DEFAULT; RECONFIGURATION; ROBUSTNESS;
D O I
10.1016/j.nicl.2022.103108
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Multiple sclerosis is a neuroinflammatory and neurodegenerative disorder of the central nervous system that can be considered a network disorder. In MS, lesional pathology continuously disconnects structural pathways in the brain, forming a disconnection syndrome. Complex functional network changes then occur that are poorly un-derstood but closely follow clinical status. Studying these structural and functional network changes has been and remains crucial to further decipher complex symptoms like cognitive impairment and physical disability. Recent insights especially implicate the importance of monitoring network hubs in MS, like the thalamus and default-mode network which seem especially hit hard. Such network insights in MS have led to the hypothesis that as the network continues to become disconnected and dysfunctional, exceeding a certain threshold of network efficiency loss leads to a "network collapse". After this collapse, crucial network hubs become rigid and overloaded, and at the same time a faster neurodegeneration and accelerated clinical (and cognitive) progression can be seen. As network neuroscience has evolved, the MS field can now move towards a clearer classification of the network collapse itself and specific milestone events leading up to it. Such an updated network-focused conceptual framework of MS could directly impact clinical decision making as well as the design of network -tailored rehabilitation strategies. This review therefore provides an overview of recent network concepts that have enhanced our understanding of clinical progression in MS, especially focusing on cognition, as well as new concepts that will likely move the field forward in the near future.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis
    Fedicova, Miriam
    Mikula, Pavol
    Gdovinova, Zuzana
    Vitkova, Marianna
    Zilka, Norbert
    Hanes, Jozef
    Frigova, Lydia
    Szilasiova, Jarmila
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [32] The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'
    Cantero-Fortiz, Yahveth
    Boada, Merce
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [33] Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms
    Shepard, C. Joy
    Cline, Sara G.
    Hinds, David
    Jahanbakhsh, Seyedehameneh
    Prokop, Jeremy W.
    PHYSIOLOGICAL GENOMICS, 2019, 51 (11) : 562 - 577
  • [34] Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process
    Yazdi, Azadeh
    Ghasemi-Kasman, Maryam
    Javan, Mohammad
    JOURNAL OF NEUROSCIENCE RESEARCH, 2020, 98 (03) : 524 - 536
  • [35] Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis
    Ellis, Terry
    Motl, Robert W.
    JOURNAL OF NEUROLOGIC PHYSICAL THERAPY, 2013, 37 (02): : 85 - 90
  • [36] Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview
    Deleu, Dirk
    Mesraoua, Boulenouar
    Canibano, Beatriz
    Melikyan, Gayane
    Al Hail, Hassan
    El-Sheikh, Lubna
    Ali, Musab
    Al Hussein, Hassan
    Ibrahim, Faiza
    Hanssens, Yolande
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (02) : 249 - 260
  • [37] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
  • [38] A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease
    Spiegelstein, Ofer
    Mimrod, Dorit
    Rabinovich, Laura
    Eyal, Eli
    Sprenger, Craig
    Elgart, Anna
    Samara, Emil
    Morganroth, Joel
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 49 - 59
  • [39] A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis
    Granstrom, Anna Lof
    Markljung, Ellen
    Fink, Katharina
    Nordenskjold, Edvard
    Nilsson, Daniel
    Wester, Tomas
    Nordenskjold, Agneta
    JOURNAL OF PEDIATRIC SURGERY, 2014, 49 (04) : 622 - 625
  • [40] A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis
    Van Hecke, Wim
    Costers, Lars
    Descamps, Annabel
    Ribbens, Annemie
    Nagels, Guy
    Smeets, Dirk
    Sima, Diana M.
    BRAIN SCIENCES, 2021, 11 (09)